Cargando…
A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
Previous work from our laboratory showed that a CB2 selective agonist, O-1966, blocked the proliferative response of C57BL/6 mouse spleen cells exposed to spleen cells of C3HeB/FeJ mice in vitro in the mixed lymphocyte reaction (MLR). The MLR is widely accepted as an in vitro correlate of in vivo gr...
Autores principales: | Jayarajan, Senthil, Meissler, Joseph J., Adler, Martin W., Eisenstein, Toby K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850832/ https://www.ncbi.nlm.nih.gov/pubmed/35185546 http://dx.doi.org/10.3389/fphar.2021.804950 |
Ejemplares similares
-
Cannabinoid Receptor Agonist Inhibits Atrial Electrical Remodeling in a Tachypaced Ex Vivo Rat Model
por: Lee, Danielle I., et al.
Publicado: (2021) -
CELL-MEDIATED CYTOTOXICITY DURING REJECTION AND ENHANCEMENT OF ALLOGENEIC SKIN GRAFTS IN RATS
por: Peter, Hans-Hartmut, et al.
Publicado: (1972) -
Delayed allogeneic skin graft rejection in CD26-deficient mice
por: Zhao, Xiangli, et al.
Publicado: (2018) -
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016) -
Treatment With Melatonin After Corneal Graft Attenuates Rejection
por: Zhu, Ziqian, et al.
Publicado: (2021)